Aug 2026· Biological chemistry· 0 citations· 80 references
Medicine
TL;DR
Recent structural and mechanistic advances of retron immune systems are discussed, including how distinct retron types deploy different effectors and phage-factor-sensing strategies while preserving a shared msDNA-centered regulatory paradigm.
Abstract
Abstract Retrons recently emerged as widespread anti-phage systems in which a dedicated reverse transcriptase (RT) produces multicopy single-stranded DNA (msDNA) that regulates associated effector proteins. Once regarded as peculiar retroelements of unknown function, retrons are now understood to operate as modular defense platforms in which the RT–msDNA module maintains nucleases, hydrolases or other effector domains in an inactive state until a phage-trigger perturbs the complex. Current biochemical and cryo-EM structural studies across different retron types have begun to define a unifying mechanism for retron-mediated immunity. Despite substantial variation in architecture and effector types, these studies converge on a common principle: msDNA acts as a structural and functional hub that scaffolds multimeric assemblies, occludes catalytic sites or stabilizes inactive effector conformations. Phage infection is sensed through perturbation of the msDNA, including cleavage, modification or binding by phage-encoded factors, thereby activating the effector to trigger an immune response. Here, we discuss recent structural and mechanistic advances of retron immune systems. We detail how distinct retron types deploy different effectors and phage-factor-sensing strategies while preserving a shared msDNA-centered regulatory paradigm. We further place retrons in the broader landscape of bacterial defense, comparing their regulatory logic with that of toxin–antitoxin modules and other immune systems.
The prokaryotic type 2 defense-associated reverse transcriptase (DRT2) system mediates antiviral defense by catalyzing the rolling-circle reverse transcription of a noncoding RNA (ncRNA) and producing the toxic Neo protein that arrests bacterial growth. However, the mechanisms underlying DRT2 activation and effector fu...
Yu-Shan Xia, Hua Qi, Xin-Yang Wei et al.· Cell Host and Microbe· 0 citations
Antiviral defence systems frequently utilise cyclic nucleotide second messengers. A prominent example is the type III CRISPR-Cas system, which generates cyclic oligoadenylates (cOA) on detecting viral RNA. cOA molecules can bind and activate a wide range of effectors to provide antiviral defence. In both prokaryotes an...
Yu Sun, Stephen McMahon, S. Synowsky et al.· bioRxiv· 0 citations
Abstract Prokaryotic Argonautes (pAgos) are widely distributed and provide immunity against invading DNA. Based on their domain architecture, pAgos are classified into three major groups: long-A, long-B, and short pAgos. Among them, long-B pAgos remain the least understood subgroup. Here, we show that a long-B pAgo-nuc...
Min Liu, Qin Yu, Xiao-Ruo Zhang et al.· Nucleic Acids Research· 0 citations
Single stranded RNA (ssRNA) and single stranded DNA (ssDNA) bacteriophages represent a key component of the global virome, yet the host genetic networks supporting their infection cycles remain poorly understood. Here, we present a comprehensive, genome-wide mapping of the genetic landscape regulating infection cycles...
This review systematically summarizes the molecular basis of UPS-mediated plant antiviral immunity, as well as convergent pathogenic strategies adopted by diverse viruses to perturb ubiquitin signaling, suppress host immune responses, and reprogram the intracellular environment.
Z. Chu, Donghai Wang, Wang-Yun Zhang et al.· Plants· 0 citations
Compact viral genomes encode sophisticated strategies to reprogram host gene expression, often by co-opting rather than replacing RNA polymerase. How bacteriophages achieve such control in Mycobacteria remains largely unknown. Here, time-resolved interaction proteomics of mycobacteriophage D29 infection identifies a co...
David R. Parker, Shrestha Ghosh, Adela Dujiskova et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.